highperformr logo

Absci's Overview

Total employees188
HeadquartersVancouver
Founded2011

Absci (NASDAQ: ABSI) is a generative AI drug creation company at the forefront of revolutionizing the therapeutic discovery process. Its Integrated Drug Creation™ platform synergizes cutting-edge artificial intelligence models with scalable wet-lab technologies to design, build, test, and discover novel biologic drug candidates. Absci's mission is to significantly accelerate the pace of drug discovery and development, aiming to bring more effective medicines to patients by translating innovative ideas into viable drugs with unprecedented speed and a higher probability of success. They focus on creating next-generation therapeutics through a deep understanding of protein function and design.

Where is Absci's Headquarters?

HQ Function

The headquarters serves as Absci's primary hub for research and development, integrating advanced AI research with extensive wet-lab operations for its Integrated Drug Creation™ platform. It also houses corporate, administrative, and operational functions.

Notable Features:

The facility features custom-designed, state-of-the-art laboratories equipped for high-throughput screening, synthetic biology, protein engineering, and data sciences. It's engineered to support Absci's unique de novo AI drug creation processes and large-scale data generation.

Work Culture:

Absci fosters a work culture centered on innovation, intense collaboration between computational scientists and bench biologists, and a shared passion for solving complex biological challenges. The environment is dynamic and mission-driven, encouraging scientific rigor and embracing cutting-edge technological advancements.

HQ Significance:

The Vancouver headquarters is critical to Absci's operational strategy, concentrating its core proprietary technologies, advanced research capabilities, and a significant portion of its specialized scientific talent. Its location offers access to a growing life sciences community and talent pool.

Values Reflected in HQ: The headquarters embodies Absci's commitment to pioneering scientific discovery, technological innovation, and the seamless integration of artificial intelligence with biological research to redefine therapeutic development.

Location:

While its primary physical research and corporate operations are based in the United States (Vancouver, WA, and New York, NY), Absci's impact and collaborations are global. The company engages in strategic partnerships with pharmaceutical and biotechnology companies worldwide, applying its AI-driven drug creation platform to diverse therapeutic targets. Its technology and drug candidates have the potential for global health impact, addressing unmet medical needs across various international markets.

Street Address:

18181 SW Lower Boones Ferry Rd

City:

Vancouver

State/Province:

WA

Country:

USA

Absci's Global Presence

New York, NY, USA

Address: 3 World Trade Center, 175 Greenwich St, New York, NY 10007

Serves as a focused center for pioneering AI research and algorithm development, directly supporting and enhancing the drug discovery capabilities of the main Vancouver operations. It aims to attract top-tier AI talent and foster breakthroughs in computational drug creation.

Buying Intent Signals for Absci

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Absci

As of April 2025, Absci' leadership includes:

Sean McClain - Founder & Chief Executive Officer
Zachary Jonasson, Ph.D. - Chief Financial Officer & Chief Business Officer
Andreas Busch, Ph.D. - Chief Innovation Officer
Sarah Korman, J.D. - Chief Legal Officer & Corporate Secretary
Denise Dettore - Chief People Officer
Matthew Weinstock, Ph.D. - Chief Technology Officer
Laurens Kleijn, Ph.D. - Chief Operating Officer

Investors of Absci

Absci has been backed by several prominent investors over the years, including:

Redmile Group
Casdin Capital
Fidelity Management & Research Company
Perceptive Advisors
ArrowMark Partners
BlackRock
Thomas Tull (U.S. Innovative Technology Fund)
Life tehát Ventures
ARTIS Ventures
WRF Capital

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

In the past 12 months, Absci has strengthened its executive team with key hires in operations and finance, and seen a transition in its Chief Scientific/Innovation Officer role. These changes support the company's strategic focus on scaling its AI-driven drug creation platform.

Departures

Greg Schiffman, Greg Schiffman departed from his role as Chief Financial Officer.

New Appointments:

Laurens Kleijn, Ph.D., Dr. Laurens Kleijn appointed as new Chief Operating Officer.
Zachary Jonasson, Ph.D., Dr. Zachary Jonasson appointed as new Chief Financial Officer and Chief Business Officer.
Andreas Busch, Ph.D., Dr. Andreas Busch transitioned to the new role of Chief Innovation Officer from Chief Scientific Officer.

Technology (Tech Stack) used by Absci

Discover the tools Absci uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Absci Email Formats and Examples

Absci commonly utilizes the [first initial][last name]@absci.com email format. This pattern is prevalent in many technology and biotechnology companies, allowing for relatively straightforward professional communication. For example, an employee named Jane Doe would likely have an email address such as jdoe@absci.com.

[first_initial][last]@absci.com

Format

jdoe@absci.com

Example

85%

Success rate

News and media

Absci Press Release (via Business Wire)May 28, 2024

Absci to Present New Data on De Novo Generative AI Antibody Design with Wet Lab Validation at Upcoming Scientific Conferences

Absci announced it will present new data showcasing its capabilities in de novo generative AI antibody design, including wet lab validation of these computationally derived antibodies. The presentations are scheduled for the PEGS Boston Summit and The Protein Engineering Summit Europe (PEGS Europe), highlighting advancements in creating therapeutic candidates with high success rates....more

Absci Press Release (via Business Wire)March 7, 2024

Absci Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress

Absci reported its financial results for the fourth quarter and full year ended December 31, 2023. The company also provided a corporate update, highlighting progress in its drug creation programs, advancements in its AI platform, and ongoing strategic partnerships. Key achievements included initial de novo antibody designs and progression of partnered programs....more

Absci Press Release (via Business Wire)February 20, 2024

Absci Appoints Laurens Kleijn, Ph.D., as Chief Operating Officer

Absci announced the appointment of Laurens Kleijn, Ph.D., as its Chief Operating Officer. Dr. Kleijn brings extensive experience in biopharmaceutical operations and development, and will be responsible for scaling Absci's operations, enhancing its platform capabilities, and advancing its internal and partnered pipeline programs....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Absci, are just a search away.